Source: Law.com – Newswire
In one of the first rulings to apply the U.S. Supreme Court’s “nerve center” test for corporate citizenship, a federal judge has ruled that, since GlaxoSmithKline’s executive headquarters is in Philadelphia, the company cannot remove a products liability lawsuit from a Pennsylvania state court to federal court. The ruling, if followed by other federal judges, could prove a major setback for GSK because it would face the prospect of a Philadelphia jury in defending itself against a growing wave of drug lawsuits.
Read the rest of the story…
For Big Pharma, ‘Nerve Center’ Test May Be Unnerving
July 1, 2010 Leave a Comment
Speak Your Mind
